Clinical Neurology and Neurosurgery
Volume 111, Issue 1 , Pages 54-56 , January 2009

Association of a history of varicella virus infection with multiple sclerosis

  • Mayela Rodríguez-Violante

      Affiliations

    • Neurodegenerative Diseases Clinical Research Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
    • ,
  • Graciela Ordoñez

      Affiliations

    • Neuroimmunology Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
    • ,
  • Jesus Ramirez Bermudez

      Affiliations

    • Department of Neuropsychiatry, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
    • ,
  • Julio Sotelo

      Affiliations

    • Neuroimmunology Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
    • ,
  • Teresa Corona

      Affiliations

    • Neurodegenerative Diseases Clinical Research Unit, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
    • Corresponding Author InformationCorresponding author at: Instituto Nacional de Neurología y Neurocirugía, Insurgentes Sur 3877, Tlalpan, Mexico City 14269, Mexico. Tel.: +52 55 56 06 45 32; fax: +52 55 56 06 45 32.

Received 6 December 2007 ,Revised 15 July 2008 ,Accepted 15 July 2008.

References 

  1. Corona T, Román G. Multiple sclerosis in Latin America. Neuroepidemiology. 2006;26:1–3
  2. Corona T, Rodríguez LJ, Otero E, Stopp L. Multiple sclerosis in México: hospital cases at the National Institute of Neurology and Neurosurgery. Neurología. 1996;11:170–173
  3. Gonzalez O, Sotelo J. Is the frequency of multiple sclerosis increasing in México?. J Neurol Neurosurg Psychiatry. 1995;59:528–530
  4. De la Maza M, García J, Bernal J, Fuentes M. Revisión de la Epidemiología de la Esclerosis Múltiple en México. Rev Neurol. 2000;31:494–495
  5. Velazquez M, Macías M, Rivera V, Lozano J. Esclerosis Multiple en México: un estudio multicéntrico. Rev Neurol. 2003;36(11):1019–1022
  6. Dagleish A. Viruses and multiple sclerosis. Acta Neurol Scand. 1997;169(Suppl):8–15
  7. Fernández R, Celma M. Virus y desmielinización: ¿por qué sospechar la implicación de virus en la etiología de la esclerosis múltiple?. Rev Neurol. 2002;35(10):964–972
  8. Poser CM. The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect. Clin Neurol Neurosurg. 2006;108(March (3)):227–233
  9. Alvarez R, Cour I, Kanaan A, Benedicto M, Martin-Estefanía C, Arroyo R, et al. Detection of viral genomes of the Herpesviridae family in multiple sclerosis patients by means of the polymerase chain reaction. Enfermedades infecciosas y Microbiología clínica. 2000;18(5):223–228
  10. Haahr S, Moller-Larsen A, Pedersen E. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group. Clin Exp Immunol. 1983;51(2):197–206
  11. Sanders V, Felisan S, Waddell A, Tourtellotte W. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polimerase chain reaction. J Neurovirol. 1996;2(4):249–258
  12. Alvarez-Lafuente R, Martin-Estefania C, De las Heras V, Castrillo C, Cour I, Picazo JJ, et al. Prevalence of herpes virus DNA in MS patients and healthy blood donors. Acta Neurol Scand. 2002;105(2):95–99
  13. Al-Shammari S, Nelson R, Voevodin A. HHV-6 DNAemia in patients with multiple sclerosis in Kuwait. Acta Neurol Scand. 2003;107(2):122–124
  14. Alvarez-La Fuente R, García-Montojo M, De la Heras V, Bartolome M, Arroyo R. Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients. J Clin Virol. 2006;37(Suppl 1):S24–26
  15. Alvarez-La Fuente R, De las Heras V, Bartolome M, García-Montojo M, Arroyo R. Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study. Brain Pathol. 2006;16(1):20–27
  16. Ross R. The varicella zoster virus and multiple sclerosis. J Clin Epidemiol. 1998;51(7):533–535
  17. Ross R, Nicolle L, Dawood MR, Cheang M, Feschuk C. Varicella Zoster antibodies after herpes zoster, varicella and multiple sclerosis. Can J Neurol Sci. 1997;24(May (2)):137–139
  18. Ross R, Nicolle L, Cheang M. The varicella zoster virus: a pilot trial of a potential therapeutic agent in multiple sclerosis. J Clin Epidemiol. 1997;50(1):63–68
  19. Ross RT, Cheang M, Landry G, Klassen L, Doerksen K. Herpes zoster and multiple sclerosis. Can J Neurol Sci. 1999;26(1):29–32
  20. Haahr S, Plesner A, Vestergaard B, Hollsberg P. A role of late Epstein Barr virus infection in multiple sclerosis. Acta Neurol Scand. 2004;109(4):270–275
  21. Höllsberg P, Kusk M, Bech E, Hansen HJ, Jakobsen J, Haahr S. Presence of Epstein-Barr virus and Human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity. Acta Neurol Scand. 2005;112(6):395–402
  22. Haahr S, Höllsberg P. Multiples sclerosis is linked to Epstein-Barr virus infection. Rev Med Virol. 2006;16(5):297–310
  23. Ross RT, Nicolle LE, Cheang M. Varicella zoster virus and multiple sclerosis in a Hutterite population. J Clin Epidemiol. 1995;48(11):1319–1324
  24. Perez-Cesari C, Saniger MM, Sotelo J. Frequent association of multiple sclerosis with varicella and zoster. Acta Neurol Scand. 2005;112(6):417–419
  25. Sotelo J, Ordoñez G, Pineda B. Varicella-zoster virus at relapses of multiple sclerosis. J Neurol. 2007;254(4):493–500
  26. Ordoñez G, Pineda B, Garcia-Navarrete R, Sotelo J. Brief presence of varicella-zoster viral DNA in mononuclear cells during relapses of multiple sclerosis. Arch Neurol. 2004;61(4):529–532
  27. Tarrats R, Ordoñez G, Rios C, Sotelo J, Varicella . ephemeral breastfeeding and eczema as risk factors for multiple sclerosis in Mexicans. Acta Neurol Scand. 2002;105(February (2)):88–94
  28. Marrie RA, Wolfson C. Multiple sclerosis and varicella zoster virus infection: a review. Epidemiol Infect. 2001;127(2):315–325
  29. Mc Donald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel of multiple sclerosis. Ann Neurol. 2001;50:121–127
  30. Lubin F. Clinical features and diagnosis of multiple sclerosis. Neurol Clin. 2005;23(1):1–15
  31. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale. Neurology. 1983;33:1444–1452
  32. Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006;5(11):932–936
  33. Daasrath P, Ong ES, Lee VJ. Seroepidemiology of varicella and the reliability of a self-reported history of varicella infection in Singapore military recruits. Ann Acad Med Singapore. 2007;36:636–641
  34. Watson B, Civen R, Reynolds M, Heath K, Perella D, Carbajal T, et al. Validity of self-reported varicella disease history in pregnant women attending prenatal clinics. Public health Rep. 2007;122:499–506
  35. Alvarez MT, Torres J, Damasio-Santana L, Gomez A, Fernandez-Quintanilla G, Tapia-Conyer R, et al. Susceptibility to varicela-zoster infection in inidividuals 1–29 years of age in Mexico. Arch Med Res. 1999;30(60):63
  36. Cordova J, Vargas S, Sotelo J. Western and Asian features of multiple sclerosis in Mexican Mestizos. Clin Neurol Neurosurg. 2007;109(2):146–151

PII: S0303-8467(08)00282-5

doi: 10.1016/j.clineuro.2008.07.007

Clinical Neurology and Neurosurgery
Volume 111, Issue 1 , Pages 54-56 , January 2009

Article Tools